{"id":5621,"date":"2020-10-29T14:13:19","date_gmt":"2020-10-29T13:13:19","guid":{"rendered":"https:\/\/aliber.org\/web\/?p=5621"},"modified":"2020-10-29T14:13:19","modified_gmt":"2020-10-29T13:13:19","slug":"retransmision-viii-encuentro-iberoamericano-de-enfermedades-raras","status":"publish","type":"post","link":"https:\/\/aliber.org\/web\/2020\/10\/29\/retransmision-viii-encuentro-iberoamericano-de-enfermedades-raras\/","title":{"rendered":"Retransmisi\u00f3n VIII Encuentro Iberoamericano de Enfermedades Raras"},"content":{"rendered":"<p>El Comit\u00e9 Organizador del VIII Encuentro \/ Congreso Iberoamericano de Enfermedades Raras, Hu\u00e9rfanas o Poco Frecuentes cerr\u00f3 el pasado 27 de octubre de 2020 las inscripciones para participar en \u00e9l, al alcanzar un total de 800 personas inscritas.<\/p>\n<p>Como hemos continuado recibiendo solicitudes y se han quedado personas por fuera de la inscripci\u00f3n, ALIBER ha habilitado un canal de youtube para que las personas que quieran seguir el Encuentro, lo puedan hacer en directo.<\/p>\n<p>Los esperamos a las 3:00 p.m. de los d\u00edas 29, 30 y 31 de octubre de 2020 (Hora Espa\u00f1a).<\/p>\n<p><iframe title=\"VIII ENCUENTRO IBEROAMERICANO DE ENFERMEDADES RARAS, HU\u00c9RFANAS O POCO FRECUENTES -ALIBER\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/ODaFc3B-lzg?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El Comit\u00e9 Organizador del VIII Encuentro \/ Congreso Iberoamericano de Enfermedades Raras, Hu\u00e9rfanas o Poco Frecuentes cerr\u00f3 el pasado 27 de octubre de 2020 las inscripciones para participar en \u00e9l,<a href=\"https:\/\/aliber.org\/web\/2020\/10\/29\/retransmision-viii-encuentro-iberoamericano-de-enfermedades-raras\/\">[&#8230;]<\/a><\/p>\n","protected":false},"author":2,"featured_media":5622,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-5621","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aliber"],"_links":{"self":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/5621","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/comments?post=5621"}],"version-history":[{"count":0,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/5621\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/media?parent=5621"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/categories?post=5621"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/tags?post=5621"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}